Avian Mycoplasmosis in Poultry: Molecular Diagnostics and Control Strategies

Introduction

Avian mycoplasmosis comprises a group of economically significant respiratory and systemic diseases of poultry caused by species within the genus Mycoplasma. Among these, Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the most clinically relevant pathogens in commercial chicken and turkey flocks worldwide. MG is the primary etiologic agent of chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, while MS causes infectious synovitis and subclinical respiratory infections. Both organisms exhibit fastidious growth requirements, weak immunogenicity, and the capacity for vertical transmission via the egg, rendering eradication difficult once established in a flock [1, 2]. This reference article provides an exhaustive examination of the molecular diagnostic approaches and integrated control strategies for avian mycoplasmosis in poultry, with emphasis on polymerase chain reaction (PCR) based detection, serological monitoring, and biosecurity protocols. The content is framed for veterinary professionals, diagnosticians, and computational biologists engaged in poultry health management. For a broader context on bacterial respiratory pathogens in poultry, readers may refer to the article on Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Antimicrobial Resistance, and Poultry Vaccination.

Etiology and Pathogenesis

Mycoplasmas are the smallest self-replicating prokaryotes, lacking a cell wall and possessing a reduced genome (approximately 800 to 1000 kb). Their plasticity and lack of peptidoglycan confer intrinsic resistance to beta-lactam antimicrobials and facilitate antigenic variation through phase and size variation of surface lipoproteins [3, 4]. MG and MS colonize the mucosal surfaces of the respiratory tract, conjunctiva, and in the case of MS, the synovial membranes and joints. Adhesion to host epithelial cells is mediated by cytadhesins such as GapA and CrmA in MG [5]. Following adhesion, mycoplasmas release hydrogen peroxide and superoxide radicals, which induce ciliostasis, epithelial necrosis, and an influx of inflammatory cells [6]. The ensuing exudative airsacculitis, tracheitis, and pneumonia are hallmarks of CRD. MS additionally provokes a fibrinopurulent synovitis and tenosynovitis, leading to lameness and reduced growth performance [7]. Both MG and MS can suppress humoral and cell mediated immune responses, delaying clearance and enabling persistent infection [8]. Concurrent infection with immunosuppressive or respiratory viruses such as Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity or Infectious Bursal Disease Virus Variants exacerbates the severity of mycoplasmosis due to synergism [9].

Clinical Signs and Economic Impact

MG infection in chickens presents as rales, coughing, nasal discharge, conjunctivitis, and decreased feed conversion. In layers, egg production may drop by 10 to 30 percent, and eggshell quality deteriorates. Turkey poults develop swollen infraorbital sinuses, dyspnea, and high mortality if untreated [10]. MS infection manifests as bilateral swelling of the hock and footpad joints, lameness, breast blisters, and a characteristic respiratory component. Subclinical MS infection is common in broilers, leading to condemnation at slaughter due to airsacculitis [11]. The economic losses attributable to MG and MS include reduced body weight gain, increased feed conversion ratio, mortality, culling, medication costs, and trade restrictions on breeding stock. A meta-analysis of field studies estimated that MG negative flocks outperform positive flocks by 5 to 12 percent in production efficiency [12].

Molecular Diagnostics

PCR Based Detection

Conventional and real time PCR assays have become the gold standard for direct detection of MG and MS in clinical specimens due to their high sensitivity and specificity relative to culture. Swabs collected from the choanal cleft, trachea, or air sacs, as well as exudate from sinuses or joints, are suitable sample types. DNA extraction methods using silica membrane columns or magnetic beads yield template suitable for amplification [13]. Conventional PCR targeting the 16S rRNA gene or species specific sequences such as the mgc2 gene for MG and the vlhA gene for MS can detect as few as 10 to 100 colony forming units per reaction [14, 15]. Real time PCR using hydrolysis probes offers quantification and reduced risk of cross contamination. A multiplex real time PCR assay that simultaneously differentiates MG and MS has been validated for routine diagnostic use [16]. The analytical sensitivity of these assays approaches 1 to 10 genome copies per reaction, and clinical sensitivity exceeds 95 percent compared to culture [17]. For whole genome characterization, next generation sequencing (NGS) has been applied to investigate transmission chains and antimicrobial resistance determinants; however, NGS is not yet routine in diagnostic laboratories. Molecular typing methods such as multilocus sequence typing (MLST) and restriction fragment length polymorphism (RFLP) analysis of the mgc2 or vlhA genes are used for epidemiological investigations [18, 19].

Serological Monitoring

Serological tests are employed for flock level surveillance because individual bird serology is unreliable due to variable antibody responses. The most widely used methods are the serum plate agglutination (SPA) test, the hemagglutination inhibition (HI) test, and enzyme linked immunosorbent assays (ELISA). SPA is rapid and inexpensive but has low specificity due to cross reactivity with avian intestinal spirochetes and Mycoplasma species other than MG and MS [20]. HI is more specific but requires fresh, standardized antigen and is labor intensive. ELISA, including indirect and blocking formats, offers high throughput quantitative results with improved specificity and sensitivity compared to SPA. Commercial ELISA kits are available for MG and MS antibody detection in serum, plasma, and egg yolk [21, 22]. For a detailed discussion of ELISA technology in a different veterinary context, see the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation, which reviews antigen capture principles applicable to serology. Seroconversion to MG occurs 1 to 2 weeks post infection; however, the window period before seroconversion and the occurrence of false negatives in early infection or in immunotolerant birds limit the sensitivity of serology alone [23]. Therefore, a combination of PCR and serology is recommended for accurate diagnosis.

Control Strategies

Biosecurity

Biosecurity is the cornerstone of mycoplasmosis prevention. Because both MG and MS can be transmitted vertically through the hatching egg, establishing and maintaining mycoplasma free breeding stock is essential. Primary breeder flocks are monitored rigorously via serology and PCR, and positive flocks are depopulated in eradication programs [24]. Lateral transmission occurs through direct bird to bird contact, airborne dust, contaminated equipment, and personnel. All in all out management, strict visitor protocols, dedicated footwear and clothing, and sanitation of housing between flocks reduce the risk of introduction [25]. Particularly in multi age farms, the proximity of different age groups facilitates transmission. Implementation of a comprehensive biosecurity plan, including rodent and wild bird control, is critical. Wild birds can serve as reservoirs for MG and MS, especially synanthropic species such as house sparrows and starlings [26]. For analogous biosecurity principles applied to viral pathogens, see the article on Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity.

Vaccination

Vaccination is used primarily to reduce clinical signs and economic losses in endemic regions or when eradication is not feasible. Live attenuated MG vaccines, such as the F strain, ts-11, and 6/85 strain, are administered via eye drop or spray to pullets and layers. These vaccines induce local and humoral immunity, but they can revert to virulence and may cause disease in turkeys [27]. MS vaccines are less widely available; a live MS vaccine derived from a temperature sensitive mutant has been developed for use in layers [28]. Bacterins (inactivated vaccines) are also available for MG and MS, providing shorter duration of immunity and requiring multiple injections. The efficacy of vaccination is influenced by the immune status of the flock, the challenge strain, and management practices. For example, administering a live MG vaccine to chicks that already harbor MS can lead to exacerbated pathology [29].

Antimicrobial Use and Resistance

Control of active infections often relies on antimicrobials that inhibit protein synthesis or DNA replication, such as tylosin, tilmicosin, tiamulin, enrofloxacin, and doxycycline. However, the lack of a cell wall renders beta lactams and cephalosporins ineffective. Mycoplasmas have demonstrated increasing resistance to macrolides and fluoroquinolones in many regions. For MG, mutations in the 23S rRNA gene (domain II and V) confer macrolide resistance, while topoisomerase gene mutations (e.g., gyrA, parC) confer fluoroquinolone resistance [30, 31]. Antimicrobial susceptibility testing of field isolates is recommended before selecting a treatment regimen; however, in vitro results do not always correlate with in vivo efficacy. Resistance to tiamulin is less common but has been reported [32]. The judicious use of antimicrobials, guided by molecular detection and susceptibility profiling, aligns with the one health approach to combat antimicrobial resistance as described in the article on Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Eradication Programs

The National Poultry Improvement Plan (NPIP) in the United States and similar programs in other countries have successfully reduced the prevalence of MG and MS in commercial breeding flocks through a combination of serological surveillance, PCR confirmation, and depopulation of positive flocks. The eradication strategy involves testing all breeder flocks at regular intervals, culling positive birds, and repopulating with certified mycoplasma free stock. Strict biosecurity and sentinel bird programs are used to monitor the repopulated facilities [33].

Diagnostic Decision Algorithm

The figure below illustrates a decision algorithm for the diagnosis and management of avian mycoplasmosis in a commercial layer or broiler breeder flock.

flowchart TD
    A[Clinical signs or production drop], > B{Collect samples}
    B, > C[Choanal cleft swab, tracheal swab, or joint exudate]
    B, > D[Blood sample for serum]
    C, > E[DNA extraction]
    E, > F[Real-time qPCR for MG and MS]
    F, > G{Result}
    G, >|MG or MS positive| H[Confirm with species-specific PCR or sequencing]
    G, >|Both negative| I[Consider other respiratory pathogens]
    H, > J[Determine antimicrobial susceptibility<br>by MIC test or genotyping]
    J, > K[Select targeted antimicrobial therapy]
    K, > L[Repeat qPCR after 14 days]
    L, > M{Clearance?}
    M, >|Yes| N[Maintain biosecurity and monitor serology]
    M, >|No| O[Review biosecurity, consider vaccination]
    D, > P[Serological test: SPA or ELISA]
    P, > Q{Seroconversion?}
    Q, >|Positive| R[Interpret with qPCR result]
    Q, >|Negative| S[Repeat serology in 2-3 weeks<br>if clinical suspicion persists]
    R, > T[Classify flock status:<br>Active infection vs. prior exposure]
    T, > K

Table of Diagnostic Methods

Conclusion

Avian mycoplasmosis remains a major constraint to poultry productivity and animal welfare worldwide. The implementation of molecular diagnostic techniques, particularly real time PCR for MG and MS, has transformed the speed and accuracy of infection detection, enabling timely intervention. Serological monitoring, despite its limitations, provides valuable herd level information when used in conjunction with direct detection methods. Control of mycoplasmosis relies on a multi pronged approach: strict biosecurity to prevent introduction, vaccination to reduce clinical impact, and rational antimicrobial therapy guided by susceptibility testing. Eradication programs have proven effective in reducing the prevalence of MG and MS in primary breeding stock. Future efforts should focus on the development of more effective vaccines, rapid point of care molecular tests, and integrated genomic surveillance systems to track resistance and transmission dynamics. Continued cross disciplinary collaboration between poultry veterinarians, molecular diagnosticians, and bioinformaticians will be essential to advance the control of these persistent pathogens.

References

[1] Kleven SH. Mycoplasmosis in poultry. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Ames: Wiley Blackwell; 2020. p. 922–961.

[2] Ley DH, Yoder HW. Mycoplasma gallisepticum infection. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell; 2008. p. 807–834.

[3] Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094–1156.

[4] Markham PF, Glew MD, Sykes JE, et al. The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett. 1994;352(3):347–352.

[5] Goh MS, Gorton TS, Forsyth MH, et al. Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology. 1998;144(11):2971–2978.

[6] Kannan TR, Baseman JB. Hemolytic and hemoxidative activities in Mycoplasma penetrans. Infect Immun. 2000;68(11):6419–6422.

[7] Lockaby SB, Hoerr FJ, Ellis AC, et al. Pathogenesis of Mycoplasma synoviae in broiler chickens. Avian Dis. 1998;42(1):162–172.

[8] Wakamatsu N, King DJ, Seal BS, et al. Immunosuppression induced by Mycoplasma gallisepticum infection in chickens. Avian Dis. 2006;50(2):273–279.

[9] Hopkins SR, Yoder HW. Influence of infectious bursal disease virus on Mycoplasma gallisepticum infection of chickens. Avian Dis. 1982;26(4):811–818.

[10] Ley DH. Mycoplasma gallisepticum infection. In: Swayne DE, editor. Diseases of Poultry. 13th ed. Ames: Wiley Blackwell; 2013. p. 857–877.

[11] Landman WJM, van Eck JHH. The significance of Mycoplasma synoviae in commercial poultry: a review. Avian Pathol. 2001;30(3):201–212.

[12] Evans JD, Leigh SA, Branton SL, et al. Effects of Mycoplasma gallisepticum vaccination on production parameters in commercial layers. Avian Dis. 2007;51(3):681–686.

[13] Raviv Z, Kleven SH. The development of diagnostic real-time TaqMan PCR for the detection of Mycoplasma synoviae in poultry. Avian Dis. 2004;48(3):525–531.

[14] Garcia M, Ikuta N, Riblet SM, et al. Evaluation and comparison of various PCR methods for detection of Mycoplasma gallisepticum. Avian Dis. 2005;49(1):125–132.

[15] Malik YS, Agarwal RK, Singh S, et al. Development of a multiplex PCR for simultaneous detection of Mycoplasma gallisepticum, M. synoviae, and M. meleagridis. Avian Dis. 2007;51(3):667–671.

[16] Mekkes DR, de Wit JJ, Czifra G, et al. Development of a real-time PCR for detection of Mycoplasma gallisepticum in poultry. Vet Microbiol. 2005;107(3-4):203–210.

[17] Lauerman LH. Advances in PCR technology for animal pathogens. In: Sachse K, Frey J, editors. PCR Detection of Microbial Pathogens. Methods in Molecular Biology. Vol. 216. Totowa: Humana Press; 2003. p. 241–252.

[18] Ferguson NM, Cookson KC, Gioia G, et al. Multilocus sequence typing of Mycoplasma gallisepticum reveals clonal diversity in commercial poultry. Vet Microbiol. 2012;155(2-4):358–367.

[19] Dijkman R, Holst S, van der Wal FJ, et al. Molecular typing of Mycoplasma synoviae from Dutch broiler breeder flocks. Avian Pathol. 2017;46(5):535–541.

[20] Kleven SH. Serologic monitoring of mycoplasma infections. Avian Dis. 1982;26(3):465–472.

[21] Czifra G, Sundquist B, Tuboly T, et al. Development of an ELISA for detection of antibodies to Mycoplasma gallisepticum in chicken sera. Avian Dis. 1990;34(3):553–559.

[22] Ewing ML, Cookson KC, Phillips RA, et al. Comparison of ELISA and serum plate agglutination for detection of Mycoplasma gallisepticum antibodies. Avian Dis. 1998;42(3):497–504.

[23] Feberwee A, de Wit JJ, Landman WJM. Induction of a Mycoplasma gallisepticum serum plate agglutination response in chickens vaccinated with ts-11. Avian Pathol. 2005;34(4):319–323.

[24] Yoder HW. A review of eradication programs for Mycoplasma gallisepticum in the USA. Avian Dis. 1989;33(4):745–753.

[25] Kleven SH. Control of avian mycoplasma infections in commercial poultry. Avian Dis. 2008;52(3):367–374.

[26] Wainwright L, Neumann E, Richey M, et al. Prevalence and molecular characterization of Mycoplasma gallisepticum and Mycoplasma synoviae in wild birds. Avian Dis. 2022;66(1):1–8.

[27] Leigh SA, Branton SL, Evans JD, et al. Safety and efficacy of the ts-11 and 6/85 Mycoplasma gallisepticum vaccines in commercial layers. Avian Dis. 2008;52(4):656–660.

[28] Feberwee A, de Wit JJ, Landman WJM. Efficacy of a temperature-sensitive mutant of Mycoplasma synoviae as a live vaccine. Avian Pathol. 2009;38(2):149–155.

[29] Buim MR, Mettifogo E, Timenetsky J, et al. Interference between Mycoplasma gallisepticum and Mycoplasma synoviae in vaccinated chickens. Avian Dis. 2010;54(4):1209–1214.

[30] Gautier-Bouchardon AV, Ferré S, Le Gall M, et al. Antimicrobial resistance in Mycoplasma gallisepticum field isolates in France. Vet Microbiol. 2014;173(3-4):269–274.

[31] Reinhardt AK, Kempf I, Kobisch M, et al. In vitro activity of enrofloxacin against Mycoplasma gallisepticum and Mycoplasma synoviae. Vet Microbiol. 2005;106(3-4):273–278.

[32] Hananeh W, Hurych J, Nevsimalova B, et al. Tiamulin susceptibility of Mycoplasma gallisepticum isolates from poultry in the Czech Republic. Avian Pathol. 2015;44(5):386–391.

[33] US Department of Agriculture. National Poultry Improvement Plan and Auxiliary Provisions. APHIS 91-55-104. Washington, DC: USDA; 2020.

[34] Nascimento ER, Yamamoto R, Herrick KR, et al. Polymerase chain reaction for detection of Mycoplasma gallisepticum. Avian Dis. 1991;35(1):93–99.

[35] Marois C, Dufour-Gesbert F, Kempf I. Comparison of phenotypic and genotypic methods for detection of Mycoplasma gallisepticum. Vet Microbiol. 2002;86(4):329–339.

[36] Moalic PY, Gesbert F, Kempf I, et al. Detection of Mycoplasma synoviae in clinical samples by real-time PCR. J Vet Diagn Invest. 2005;17(3):223–228.

[37] Banai M, Kahane I, Feldmann R, et al. Use of a PCR for detection of Mycoplasma gallisepticum in chicken tracheal swabs. Avian Dis. 1997;41(2):395–400.

[38] Garcia M, Jackwood MW, Headley SR, et al. Comparison of PCR and culture for detection of Mycoplasma gallisepticum in chickens. Avian Dis. 1996;40(4):902–907.

[39] Kempf I, Gesbert F, Guittet M, et al. Evaluation of the protective efficacy of a live Mycoplasma gallisepticum vaccine in commercial layers under field conditions. Avian Pathol. 1997;26(1):193–206.

[40] Leigh SA, Branton SL, Evans JD, et al. Efficacy of the F strain of Mycoplasma gallisepticum as a vaccine in commercial layers. Avian Dis. 2005;49(3):374–379.

[41] Whithear KG. Control of avian mycoplasmoses by vaccination. Rev Sci Tech. 1996;15(4):1527–1545.

[42] Catania S, Gobbo F, Ramadori G, et al. Evaluation of a multi-locus sequence typing scheme for Mycoplasma synoviae. Vet Microbiol. 2016;191:40–45.

[43] Ferguson NM, Cookson KC, Gioia G, et al. Genomic analysis of Mycoplasma gallisepticum isolates from outbreaks in commercial turkeys. Vet Microbiol. 2013;166(3-4):606–614.

[44] Feberwee A, de Wit JJ, Landman WJM. Induction of seroconversion in layer chickens after vaccination with ts-11. Avian Pathol. 2002;31(4):385–390.

[45] Kleven SH, King DD, Anderson DP. The effect of Mycoplasma gallisepticum vaccination on egg production in commercial egg-type chickens. Avian Dis. 1998;42(2):302–308.

[46] Raviv Z, Ferguson NM, Kleven SH. A comparative study of diagnostic methods for Mycoplasma gallisepticum detection in chickens. Avian Dis. 2005;49(3):380–385.

[47] Yoder HW. The evaluation of a DNA probe for detection of Mycoplasma gallisepticum. Avian Dis. 1990;34(4):888–893.

[48] Sato S, Shibata K, Arimura H, et al. Comparison of real-time PCR and culture for detection of Mycoplasma synoviae in chickens. J Vet Med Sci. 2011;73(7):917–921.

[49] Landman WJM, Feberwee A, van Eck JHH. A model for vertical transmission of Mycoplasma synoviae in chickens. Avian Pathol. 2002;31(5):475–481.

[50] Grodio JL, Dhondt AA, O'Connell PH, et al. Detection of Mycoplasma gallisepticum in house finches using real-time PCR. Avian Dis. 2008;52(1):88–93.